Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$201.05 - $221.7 $20,105 - $22,170
-100 Reduced 4.0%
2,402 $482,000
Q2 2023

Jul 13, 2023

BUY
$211.93 - $241.33 $530,248 - $603,807
2,502 New
2,502 $603,000
Q4 2022

Jan 23, 2023

BUY
$203.72 - $248.97 $506,651 - $619,188
2,487 New
2,487 $0
Q2 2022

Jul 25, 2022

SELL
$213.86 - $277.87 $15,397 - $20,006
-72 Reduced 2.81%
2,487 $583,000
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $1,558 - $1,789
-6 Reduced 0.23%
2,559 $675,000
Q4 2021

Feb 08, 2022

SELL
$271.6 - $314.21 $1,358 - $1,571
-5 Reduced 0.19%
2,565 $806,000
Q3 2021

Nov 16, 2021

SELL
$274.82 - $308.34 $3,023 - $3,391
-11 Reduced 0.43%
2,570 $718,000
Q2 2021

Aug 13, 2021

SELL
$251.87 - $278.14 $25,438 - $28,092
-101 Reduced 3.77%
2,581 $712,000
Q4 2017

Feb 13, 2018

BUY
$147.99 - $163.95 $396,909 - $439,713
2,682
2,682 $435,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Parisi Gray Wealth Management Portfolio

Follow Parisi Gray Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parisi Gray Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Parisi Gray Wealth Management with notifications on news.